The use and impact of European Testing Week regional awareness campaigns to increase HIV and viral hepatitis testing coverage

被引:2
|
作者
Raben, Dorthe [1 ]
Kahama, C. B. [1 ]
Combs, L. [1 ]
Stengaard, Annemarie [1 ]
Rockstroh, J. K. [2 ]
Simoes, Daniel [3 ]
Collins, Ben [4 ]
European Testing Week Working Grp
EuroTEST Steering Committee
机构
[1] Univ Copenhagen, CHIP, Rigshosp, Copenhagen, Denmark
[2] Univ Hosp Bonn, Dept Med 1, Bonn, Germany
[3] CoalitionPLUS, Paris, France
[4] ReShape Int HIV Partnerships, London, England
关键词
awareness; campaign; hepatitis; HIV; testing;
D O I
10.1111/hiv.13544
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
IntroductionSince 2013, the European Testing Week (ETW) awareness campaign has become a key regional event influencing testing efforts for HIV, viral hepatitis, and sexually transmitted infections (STIs) through participation of 720 organizations. Here, we report on a survey from May to June 2022 aimed at assessing the participant-reported impact of the campaign.MethodsAll past and current participating organizations were asked to complete an online questionnaire between 12 May and 17 June 2022. Multiple choice and open-text questions included organization information, usage of ETW to engage in local testing-related activities, and the effect of a regional campaign to reach a wider audience and generate impact.ResultsOf the 52 respondents, 34 (65%) stated first participating in ETW 5-10 years ago. ETW was used for awareness raising by 40 respondents (83%), new testing activities by 37 (77%), advocacy initiatives by 15 (31%), and training/capacity building by 18 (38%). For awareness raising, 95% used ETW to highlight the importance of and to encourage testing; for new testing activities, 74% used ETW to reach new groups. In total, 44 (85%) reported added benefits of a Europe-wide campaign compared with national/local campaigns, particularly the increased visibility and collaboration opportunities. Impact at the local level was observed by 24 (51%), and impact at a national level was observed by 20 (43%). A total of 28 (79%) reported increases in the number of tests performed and 25 (75%) reported increases in clients accessing services.ConclusionsRegional awareness campaigns reach wider audiences, boost local and national efforts to increase testing, and sensitize key populations about the critical value of testing compared with local/national campaigns.
引用
收藏
页码:154 / 160
页数:7
相关论文
共 50 条
  • [41] The potential impact of point of care (POC) diagnostics: HIV viral load and resistance testing
    Urdea, M. S.
    ANTIVIRAL THERAPY, 2014, 19 : A10 - A10
  • [42] Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic review
    Hajarizadeh, Behzad
    Kairouz, Abe
    Ottaviano, Sophie
    Ireland, Jeremy
    Willing, Alex
    Cunningham, Evan
    Webb, Paige
    Colledge-Frisby, Samantha
    Wheeler, Alice
    Leung, Janni
    Tran, Lucy
    Price, Olivia
    Vickerman, Peter
    Farrell, Michael
    Hickman, Matthew
    Dore, Gregory J.
    Bergenstrom, Anne
    Degenhardt, Louisa
    Grebely, Jason
    LANCET GLOBAL HEALTH, 2023, 11 (12): : E1885 - E1898
  • [43] Viral hepatitis testing patterns among HIV-positive individuals in the UK Collaborative HIV Cohort (UKCHIC) study
    Thornton, A.
    Bhagani, S.
    Burroughs, A.
    Chadwick, D.
    Dunn, D.
    Fisher, M.
    Gilson, R.
    Jose, S.
    Main, J.
    Nelson, M.
    Rodger, A.
    Taylor, C.
    Sabin, C.
    HIV MEDICINE, 2014, 15 : 91 - 92
  • [44] Testing for HIV, Sexually Transmitted Infections, and Viral Hepatitis in Jails: Still a Missed Opportunity for Public Health and HIV Prevention
    Flanigan, Timothy P.
    Zaller, Nickolas
    Beckwith, Curt G.
    Bazerman, Lauri B.
    Rana, Aadia
    Gardner, Adrian
    Wohl, David A.
    Altice, Frederick L.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 55 : S78 - S83
  • [45] TESTING FOR HEPATITIS B VIRUS (HBV) ALONE DOES NOT INCREASE VACCINE COVERAGE IN NON-IMMUNIZED PERSONS
    Bottero, J.
    Boyd, A.
    Gozlan, J.
    Lemoine, M.
    Collignon, A.
    Boo, N.
    Dhotte, P.
    Varsat, B.
    Charlois, C.
    Cha, O.
    Picard, O.
    Pauti, M. -D.
    Campa, P.
    Silbermann, B.
    Bary, M.
    Rougier, H.
    Girard, P. -M.
    Lacombe, K.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S21 - S21
  • [46] EFFORTS TO INCREASE THE USE OF HIV TESTING SERVICES : WHAT INTERVENTIONS HAVE WORKED IN THAILAND?
    Jenkins, Chris
    Jourdain, Gonzague
    Arunothong, Surachet
    Sirirungsi, Wasna
    Kunstadter, Peter
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2017, 48 (02) : 282 - 296
  • [47] Use of indirect evidence from HIV self-testing to inform the WHO hepatitis C self-testing recommendation
    Fonner, Virginia A.
    Luhmann, Niklas
    Siegfried, Nandi
    Johnson, Cheryl
    Baggaley, Rachel
    Ford, Nathan
    Jamil, Muhammad S.
    BMJ GLOBAL HEALTH, 2023, 8 (02):
  • [48] Software automated testing: A solution to maximize the test plan coverage and to increase software reliability and quality in use
    Catelani, Marcantonio
    Ciani, Lorenzo
    Scarano, Valeria L.
    Bacioccola, Alessandro
    COMPUTER STANDARDS & INTERFACES, 2011, 33 (02) : 152 - 158
  • [49] Using the electronic medical record to increase testing for HIV and hepatitis C virus in an Appalachian emergency department
    Carmen N. Burrell
    Melinda J. Sharon
    Stephen Davis
    Judith Feinberg
    Elena M. Wojcik
    Julia Nist
    Owen Lander
    Valerie Boley
    Justin Burns
    Ian B. K. Martin
    BMC Health Services Research, 21
  • [50] Using the electronic medical record to increase testing for HIV and hepatitis C virus in an Appalachian emergency department
    Burrell, Carmen N.
    Sharon, Melinda J.
    Davis, Stephen
    Feinberg, Judith
    Wojcik, Elena M.
    Nist, Julia
    Lander, Owen
    Boley, Valerie
    Burns, Justin
    Martin, Ian B. K.
    BMC HEALTH SERVICES RESEARCH, 2021, 21 (01)